MeSH D008060 - lipodystrophy
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Amryt Pharma | Metreleptin | Myalept | 2014-02-24 | |||
| Metreleptin | Myalepta | 2018-07-29 |
Clinical Trials
Historical Success Rate
Phase 1
50%3/6
Phase 2
60%6/10
Phase 3
44%4/9
Approved: 1Overall Success rate: 13%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use